GenturaDx appoints Dr Geoffrey McKinley senior VP
This article was originally published in Clinica
Molecular diagnostics company GenturaDx has appointed Dr Geoffrey McKinley senior vice-president of research and development. Dr McKinley was previously responsible for research and development to support molecular biology assay, consumable and instrumental development at Osmetech, now a wholly-owned subsidiary of molecular diagnostics specialist GenMark Dx.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.